Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users
Staszewski, S.; Haberl, A.; Gute, P.; Nisius, G.; Miller, V.; Carlebach, A.
Antiviral Therapy 3(Suppl 4): 55-56
1998
ISSN/ISBN: 1359-6535 PMID: 10723511 Document Number: 489011
Human immunodeficiency virus (HIV)-infected, active intravenous drug users received once-daily therapy consisting of a combination of didanosine (2',3'-dideoxyinosine or DDI), lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine or 3TC] and nevirapine. Preliminary results for the first 24 weeks show that the regimen provides potent immunological and antiviral effects.
Document emailed within 1 workday
Related Documents
Manosuthi, W.; Kiertiburanakul, S.; Chaovavanich, A.; Sungkanuparph, S. 2007: Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients Journal of the Medical Association of Thailand 90(2): 244-250Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Grund, J.P.; Kaplan, C.D. 1989: HIV transmission in the daily ritual of intravenous drug users Nederlands Tijdschrift Voor Geneeskunde 133(17): 899-900
Raffi, F.; Reliquet, V.; Ferré, V.; Arvieux, C.; Hascoet, C.; Bellein, V.; Besnier, J.M.; Breux, J.P.; Garré, M.; May, T.; Molina, J.M.; Perré, P.; Raguin, G.; Rozenbaum, W.; Zucman, D. 2000: The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults Antiviral Therapy 5(4): 267-272
Kiertiburanakul, S.; Khongnorasat, S.; Rattanasiri, S.; Sungkanuparph, S. 2007: Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients Journal of the Medical Association of Thailand 90(2): 237-243
Zmarzły, A.; Simon, K.; Krause, K.; Rotter, K.; Gasiorowski, J. 2004: Zinc status in ex-intravenous drug users infected by HIV, without clinical presentation of AIDS Wiadomosci Lekarskie 57(5-6): 249-254
Duan, Y.J.; Zheng, X.W.; Zhen, C.H. 1995: Investigation of mortality among HIV-infected intravenous drug users in Ruili region of Yunnan province Zhonghua Liu Xing Bing Xue Za Zhi 16(2): 71-73
Poerksen, G.; Pollock, L.; Moons, P.; Chesshyre, E.; Burger, D.; Khoo, S.; Molyneux, E. 2010: Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets Antiviral Therapy 15(3): 343-350
Anekthananon, T.; Ratanasuwan, W.; Techasathit, W.; Sonjai, A.; Suwanagool, S. 2004: Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study Journal of the Medical Association of Thailand 87(7): 760-767
Vanprapar, N.; Cressey, T.R.; Chokephaibulkit, K.; Muresan, P.; Plipat, N.; Sirisanthana, V.; Prasitsuebsai, W.; Hongsiriwan, S.; Chotpitayasunondh, T.; Eksaengsri, A.; Toye, M.; Smith, M.E.; McIntosh, K.; Capparelli, E.; Yogev, R. 2010: A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand Pediatric Infectious Disease Journal 29(10): 940-944
Van Leeuwen, R.; Lange, J.M.; Nijhuis, M.; Schuurman, R.; Reiss, P.; Danner, S.A.; Boucher, C.A. 1997: Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine Antiviral Therapy 2(2): 79-90
Molina, J.M.; Chêuc, G.; Ferchal, F.; Journot, V.; Pellegrin, I.; Sombardier, M.N.; Rancinan, C.; Cotte, L.; Madelaine, I.; Debord, T.; Decazes, J.M. 1999: Results of the ALBi trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients Antiviral Therapy 4(Suppl 3): 71-74
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17
Staszewski, S.; Keiser, P.; Montaner, J.; Raffi, F.; Gathe, J.; Brotas, V.; Hicks, C.; Hammer, S.M.; Cooper, D.; Johnson, M.; Tortell, S.; Cutrell, A.; Thorborn, D.; Isaacs, R.; Hetherington, S.; Steel, H.; Spreen, W. 2001: Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial JAMA 285(9): 1155-1163
Lanzafame, M.; Nicole, S.; Rizzardo, S.; Piacentini, D.; Chiesi, S.; Lattuada, E.; Diani, E.; Carelli, M.; Vento, S.; Gibellini, D. 2018: Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir New Microbiologica 41(4): 262-267
Rajesh, L.; Ramesh, K.; Hanna, L.E.; Narayanan, P.R.; Swaminathan, S. 2010: Emergence of drug resistant mutations after single dose nevirapine exposure in HIV-1 infected pregnant women in south India Indian Journal of Medical Research 132: 509-512
Rajesh, L.; Ramesh, K.; Hanna, L.E.; Narayanan, P.R.; Swaminathan, S. 2010: Emergence of drug resistant mutations after single dose nevirapine exposure in HIV-1 infected pregnant women in south India Indian Journal of Medical Research 132: 509-512
Jones, C.; Vlahov, D. 1989: Why don't intravenous drug users use condoms? Journal of Acquired Immune Deficiency Syndromes 2(4): 416-417
Gartland, M. 2001: AVANTi 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients Antiviral Therapy 6(2): 127-134
Zimmo, S.K.; Njoh, J. 1998: Seroprevalence of syphilis and HIV in intravenous drug users Saudi Medical Journal 19(2): 189-190